MALAT-1: A novel LncRNA modulating STAT-3 regulated cystathionine-γ-lyase (CSE) in breast cancer

被引：2
|
作者：
Khater, N. [1 ]
Habashy, D. [2 ]
Youness, R. A. [3 ]
Gad, M. Z. [1 ]
机构：
[1] German Univ Cairo, Biochem Dept, Cairo, Egypt
[2] German Univ Cairo, Dept Pharmacol & Toxicol, Cairo, Egypt
[3] German Univ Cairo, Pharmaceut Biol Dept, Cairo, Egypt
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.01.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14P
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [1] A novel crosstalk between pyridoxal 5′-phosphate (PLP)-dependent enzymes, CBS and CSE, modulated by MALAT-1/STAT-3 axis
    Khater, N.
    Youness, R. A.
    Habashy, D.
    Gad, M. Z.
    ANNALS OF ONCOLOGY, 2021, 32 : S1361 - S1361
  • [2] Cystathionine- γ-lyase promotes process of breast cancer in association with STAT3 signaling pathway
    You, Jing
    Shi, Xiaoyan
    Liang, Huimin
    Ye, Juan
    Wang, Lupeng
    Han, Huanxiao
    Fang, Hongyu
    Kang, Wenyi
    Wang, Tianxiao
    ONCOTARGET, 2017, 8 (39) : 65677 - 65686
  • [3] MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer
    Mekky, Radwa Y.
    Ragab, Mai F.
    Manie, Tamer
    Attia, Abdelrahman A.
    Youness, Rana A.
    TRANSLATIONAL ONCOLOGY, 2023, 31
  • [4] MALAT-1: LncRNA ruling miR-182/PIG-C/mesothelin triad in triple negative breast cancer
    Barsoum, Farida S.
    Awad, Amany S.
    Hussein, Nada H.
    Eissa, Reda A.
    El Tayebi, Hend M.
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (12)
  • [5] Direct and indirect modulation of STAT3/CSE/H2S axis in triple negative breast cancer by non-coding RNAs: MALAT-1 lncRNA, miR-486-5p and miR-30a-5p
    Youness, Rana A.
    Khater, Nour
    El-Khouly, Aisha
    Nafea, Heba
    Manie, Tamer
    Habashy, Danira
    Gad, Mohamed Z.
    PATHOLOGY RESEARCH AND PRACTICE, 2025, 265
  • [6] Cystathionine-γ-lyase contributes to tamoxifen resistance, and the compound I194496 alleviates this effect by inhibiting the PPARγ/ACSL1/STAT3 signalling pathway in oestrogen receptor-positive breast cancer
    Fu, Han
    Han, Xue
    Guo, Wenqing
    Zhao, Xuening
    Yu, Chunxue
    Zhao, Wei
    Feng, Shasha
    Wang, Jian
    Zhang, Zhenshuai
    Lei, Kaijian
    Li, Ming
    Wang, Tianxiao
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] I157172, a novel inhibitor of cystathionine -lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3
    Wang, Lupeng
    Shi, Haimei
    Zhang, Xiaoyu
    Zhang, Xiuli
    Liu, Ya
    Kang, Wenyi
    Shi, Xiaoyan
    Wang, Tianxiao
    ONCOLOGY REPORTS, 2019, 41 (01) : 427 - 436
  • [8] The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis
    Li, Sen
    Mei, Zhoufang
    Hu, Hai-Bo
    Zhang, Xin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (09) : 6679 - 6688
  • [9] MALAT-1: LncRNA ruling miR-182/PIG-C/mesothelin triad in triple negative breast cancer (vol 216, 153274, 2020)
    Barsoum, Farida S.
    Armanious, Monica
    Awad, Amany S.
    Hussein, Nada H.
    Eissa, Reda A.
    El Tayebi, Hend M.
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 251
  • [10] Evaluation of BRCA1, STAT-1 and STAT-3 expression in non familial breast cancer from North India: An interim analysis.
    Gupta, Sameer
    Agarwal, Preeti
    Chaturvedi, Arun
    Kumar, Vijay
    Akhtar, Naseem
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345